Recently, Zhang et al analyzed the expression of DYRK2 in paired HCC and adjacent tissues from 86 patients and found that the expression of DYRK2 was more significantly downregulated in patients with a higher degree of malignancy and lower survival than in patients with a lower degree of malignancy and better survival.222. The gene discussed is DYRK2; the disease is hepatocellular carcinoma.